{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:14:35Z","timestamp":1794640475133,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Cincinnati College of Medicine Office of Research"},{"name":"German Tuberous Sclerosis Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Tuberous sclerosis complex (TSC) results in neurodevelopmental phenotypes, benign tumors, and cysts throughout the body. Recent studies show numerous rare findings in TSC. Guidelines suggest routine abdominal and chest imaging to monitor these thoracoabdominal findings, but imaging is not uniformly done across centers. Thus, the prevalence of many findings is unknown. To answer this, we categorized the clinical reads of 1398 thoracoabdominal scans from 649 patients of all ages in the Cincinnati Children\u2019s Hospital TSC Repository Database.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Typical TSC findings were present in many patients: kidney cysts (72%), kidney fat-containing angiomyolipomas (51%), kidney lipid-poor angiomyolipomas (27%), liver angiomyolipomas (19%), and lung nodules thought to represent multifocal micronodular pneumocyte hyperplasia (MMPH) (18%). While many features were more common in <jats:italic>TSC2<\/jats:italic> patients, <jats:italic>TSC1<\/jats:italic> patients had a higher prevalence of MMPH than <jats:italic>TSC2<\/jats:italic> patients (24% versus 13%, p\u2009=\u20090.05). Many rare findings (e.g., lymphatic malformations and liver masses) are more common in TSC than in the general population. Additionally, most thoracoabdominal imaging findings increased with age except kidney cysts which decreased, with the 0\u201310\u00a0years age group having the highest percentage (69% 0\u201310\u00a0years, 49% 10\u201321\u00a0years, 48% 21\u2009+\u2009years, p\u2009&lt;\u20090.001). Finally, in our population, no patients had renal cell carcinoma found on abdominal imaging.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These results show that regular thoracoabdominal scans in TSC may show several findings that should not be ignored or, conversely, over-reacted to when found in patients with TSC. Female sex, <jats:italic>TSC2<\/jats:italic> mutation, and age are risk factors for many thoracoabdominal findings. The data suggest novel interactions of genetic mutation with pulmonary nodules and age with renal cysts. Finally, in agreement with other works, these findings indicate that several rare thoracoabdominal imaging findings occur at higher rates in the TSC population than in the general population. This work supports obtaining detailed thoracoabdominal imaging in patients with TSC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02277-x","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T12:03:55Z","timestamp":1647345835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complex"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7723-3636","authenticated-orcid":false,"given":"David M.","family":"Ritter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailey K.","family":"Fessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ebrahimi-Fakhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darcy A.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Trout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Towbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"2277_CR1","doi-asserted-by":"crossref","unstructured":"Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus G. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49(4):243\u201354.","DOI":"10.1016\/j.pediatrneurol.2013.08.001"},{"issue":"13","key":"2277_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355(13):1345\u201356.","journal-title":"N Engl J Med"},{"issue":"9","key":"2277_CR3","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1177\/08830738040190091001","volume":"19","author":"DN Franz","year":"2004","unstructured":"Franz DN. Non-neurologic manifestations of tuberous sclerosis complex. J Child Neurol. 2004;19(9):690\u20138.","journal-title":"J Child Neurol"},{"issue":"2","key":"2277_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejpn.2015.11.011","volume":"20","author":"C Kingswood","year":"2016","unstructured":"Kingswood C, Bolton P, Crawford P, Harland C, Johnson SR, Sampson JR, et al. The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD). Eur J Paediatr Neurol. 2016;20(2):296\u2013308.","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"2277_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13023-018-0870-y","volume":"13","author":"D Ebrahimi-Fakhari","year":"2018","unstructured":"Ebrahimi-Fakhari D, Mann LL, Poryo M, Graf N, von Kries R, Heinrich B, et al. Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study. Orphanet J Rare Dis. 2018;13(1):117.","journal-title":"Orphanet J Rare Dis"},{"key":"2277_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","volume":"615","author":"JP Osborne","year":"1991","unstructured":"Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci. 1991;615:125\u20137.","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"2277_CR7","doi-asserted-by":"publisher","first-page":"e1005637","DOI":"10.1371\/journal.pgen.1005637","volume":"11","author":"ME Tyburczy","year":"2015","unstructured":"Tyburczy ME, Dies KA, Glass J, Camposano S, Chekaluk Y, Thorner AR, et al. Mosaic and intronic mutations in TSC1\/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing. PLoS Genet. 2015;11(11):e1005637.","journal-title":"PLoS Genet"},{"issue":"2","key":"2277_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/BJ20080281","volume":"412","author":"J Huang","year":"2008","unstructured":"Huang J, Manning BD. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J. 2008;412(2):179\u201390.","journal-title":"Biochem J"},{"issue":"1","key":"2277_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. 2001;68(1):64\u201380.","journal-title":"Am J Hum Genet"},{"key":"2277_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/TACG.S90262","volume":"10","author":"C Caban","year":"2017","unstructured":"Caban C, Khan N, Hasbani DM, Crino PB. Genetics of tuberous sclerosis complex: implications for clinical practice. Appl Clin Genet. 2017;10:1\u20138.","journal-title":"Appl Clin Genet"},{"issue":"1","key":"2277_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13023-016-0553-5","volume":"12","author":"JC Kingswood","year":"2017","unstructured":"Kingswood JC, d\u2019Augeres GB, Belousova E, Ferreira JC, Carter T, Castellana R, et al. TuberOus SClerosis registry to increase disease Awareness (TOSCA)\u2014baseline data on 2093 patients. Orphanet J Rare Dis. 2017;12(1):2.","journal-title":"Orphanet J Rare Dis"},{"key":"2277_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","volume":"123","author":"H Northrup","year":"2021","unstructured":"Northrup H, Aronow ME, Bebin EM, Bissler J, Darling TN, de Vries PJ, et al. Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations. Pediatr Neurol. 2021;123:50\u201366.","journal-title":"Pediatr Neurol"},{"issue":"9","key":"2277_CR13","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00247-018-4123-y","volume":"48","author":"CE Morin","year":"2018","unstructured":"Morin CE, Morin NP, Franz DN, Krueger DA, Trout AT, Towbin AJ. Thoracoabdominal imaging of tuberous sclerosis. Pediatr Radiol. 2018;48(9):1307\u201323.","journal-title":"Pediatr Radiol"},{"issue":"1","key":"2277_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13023-021-01917-y","volume":"16","author":"M Sauter","year":"2021","unstructured":"Sauter M, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, et al. Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA). Orphanet J Rare Dis. 2021;16(1):301.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2277_CR15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/ajmg.c.31655","volume":"178","author":"DN Franz","year":"2018","unstructured":"Franz DN, Krueger DA. mTOR inhibitor therapy as a disease modifying therapy for tuberous sclerosis complex. Am J Med Genet C Semin Med Genet. 2018;178(3):365\u201373.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"6","key":"2277_CR16","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ana.24523","volume":"78","author":"DN Franz","year":"2015","unstructured":"Franz DN, Agricola K, Mays M, Tudor C, Care MM, Holland-Bouley K, et al. Everolimus for subependymal giant cell astrocytoma: 5-year final analysis. Ann Neurol. 2015;78(6):929\u201338.","journal-title":"Ann Neurol"},{"issue":"23","key":"2277_CR17","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1212\/WNL.0000000000003400","volume":"87","author":"DA Krueger","year":"2016","unstructured":"Krueger DA, Wilfong AA, Mays M, Talley CM, Agricola K, Tudor C, et al. Long-term treatment of epilepsy with everolimus in tuberous sclerosis. Neurology. 2016;87(23):2408\u201315.","journal-title":"Neurology"},{"issue":"6","key":"2277_CR18","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.ejpn.2018.06.007","volume":"22","author":"DA Krueger","year":"2018","unstructured":"Krueger DA, Capal JK, Curatolo P, Devinsky O, Ess K, Tzadok M, et al. Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): multicentre clinical experience. Eur J Paediatr Neurol. 2018;22(6):1066\u201373.","journal-title":"Eur J Paediatr Neurol"},{"issue":"10056","key":"2277_CR19","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","volume":"388","author":"JA French","year":"2016","unstructured":"French JA, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, et al. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet. 2016;388(10056):2153\u201363.","journal-title":"Lancet"},{"issue":"13","key":"2277_CR20","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S1470-2045(14)70489-9","volume":"15","author":"DN Franz","year":"2014","unstructured":"Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, et al. Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study. Lancet Oncol. 2014;15(13):1513\u201320.","journal-title":"Lancet Oncol"},{"issue":"9869","key":"2277_CR21","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","volume":"381","author":"JJ Bissler","year":"2013","unstructured":"Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Frost M, Belousova E, et al. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2013;381(9869):817\u201324.","journal-title":"Lancet"},{"key":"2277_CR22","doi-asserted-by":"publisher","first-page":"627672","DOI":"10.3389\/fneur.2021.627672","volume":"12","author":"K Mowrey","year":"2021","unstructured":"Mowrey K, Northrup H, Rougeau P, Hashmi SS, Krueger DA, Ebrahimi-Fakhari D, et al. Frequency, progression, and current management: report of 16 new cases of nonfunctional pancreatic neuroendocrine tumors in tuberous sclerosis complex and comparison with previous reports. Front Neurol. 2021;12:627672.","journal-title":"Front Neurol"},{"key":"2277_CR23","doi-asserted-by":"crossref","unstructured":"De Sautu De Borbon EC, Guerra Vales JM, Lumbreras Bermejo C, Guerrero Ramos F, Buj Padilla MJ, Gonzalez de la Aleja J, et al. Clinical, genetic and quality-of-life study of a cohort of adult patients with tuberous sclerosis. Orphanet J Rare Dis. 2021;16(1):243.","DOI":"10.1186\/s13023-021-01878-2"},{"issue":"7","key":"2277_CR24","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","volume":"38","author":"P Yang","year":"2014","unstructured":"Yang P, Cornejo KM, Sadow PM, Cheng L, Wang M, Xiao Y, et al. Renal cell carcinoma in tuberous sclerosis complex. Am J Surg Pathol. 2014;38(7):895\u2013909.","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"2277_CR25","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41581-018-0059-6","volume":"14","author":"HC Lam","year":"2018","unstructured":"Lam HC, Siroky BJ, Henske EP. Renal disease in tuberous sclerosis complex: pathogenesis and therapy. Nat Rev Nephrol. 2018;14(11):704\u201316.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"2277_CR26","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1378\/chest.12-2813","volume":"144","author":"CJ Cudzilo","year":"2013","unstructured":"Cudzilo CJ, Szczesniak RD, Brody AS, Rattan MS, Krueger DA, Bissler JJ, et al. Lymphangioleiomyomatosis screening in women with tuberous sclerosis. Chest. 2013;144(2):578\u201385.","journal-title":"Chest"},{"issue":"7","key":"2277_CR27","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.crad.2011.02.009","volume":"66","author":"ME Adriaensen","year":"2011","unstructured":"Adriaensen ME, Schaefer-Prokop CM, Duyndam DA, Zonnenberg BA, Prokop M. Radiological evidence of lymphangioleiomyomatosis in female and male patients with tuberous sclerosis complex. Clin Radiol. 2011;66(7):625\u20138.","journal-title":"Clin Radiol"},{"issue":"5","key":"2277_CR28","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1513\/AnnalsATS.202008-911OC","volume":"18","author":"X Tian","year":"2021","unstructured":"Tian X, Glass JE, Kwiatkowski DJ, Towbin AJ, Li Y, Sund KL, et al. Lymphangioleiomyomatosis association with underlying genotype in patients with tuberous sclerosis complex. Ann Am Thorac Soc. 2021;18(5):815\u20139.","journal-title":"Ann Am Thorac Soc"},{"issue":"25","key":"2277_CR29","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.4254\/wjh.v7.i25.2603","volume":"7","author":"A Vijay","year":"2015","unstructured":"Vijay A, Elaffandi A, Khalaf H. Hepatocellular adenoma: an update. World J Hepatol. 2015;7(25):2603\u20139.","journal-title":"World J Hepatol"},{"issue":"2","key":"2277_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.crad.2009.09.014","volume":"65","author":"D Halpenny","year":"2010","unstructured":"Halpenny D, Snow A, McNeill G, Torreggiani WC. The radiological diagnosis and treatment of renal angiomyolipoma-current status. Clin Radiol. 2010;65(2):99\u2013108.","journal-title":"Clin Radiol"},{"issue":"10","key":"2277_CR31","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.jacc.2011.05.027","volume":"58","author":"RS Beroukhim","year":"2011","unstructured":"Beroukhim RS, Prakash A, Buechel ER, Cava JR, Dorfman AL, Festa P, et al. Characterization of cardiac tumors in children by cardiovascular magnetic resonance imaging: a multicenter experience. J Am Coll Cardiol. 2011;58(10):1044\u201354.","journal-title":"J Am Coll Cardiol"},{"key":"2277_CR32","doi-asserted-by":"publisher","first-page":"144815","DOI":"10.1016\/j.gene.2020.144815","volume":"753","author":"J Klinner","year":"2020","unstructured":"Klinner J, Kruger M, Brunet T, Makowski C, Riedhammer KM, Mollweide A, et al. Congenital lymphedema as a rare and first symptom of tuberous sclerosis complex. Gene. 2020;753:144815.","journal-title":"Gene"},{"issue":"6","key":"2277_CR33","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/ajmg.a.36469","volume":"164A","author":"AL Geffrey","year":"2014","unstructured":"Geffrey AL, Shinnick JE, Staley BA, Boronat S, Thiele EA. Lymphedema in tuberous sclerosis complex. Am J Med Genet A. 2014;164A(6):1438\u201342.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"2277_CR34","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/eje.0.1490273","volume":"149","author":"L Barzon","year":"2003","unstructured":"Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol. 2003;149(4):273\u201385.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2277_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4103\/atm.ATM_110_19","volume":"14","author":"K Loverdos","year":"2019","unstructured":"Loverdos K, Fotiadis A, Kontogianni C, Iliopoulou M, Gaga M. Lung nodules: a comprehensive review on current approach and management. Ann Thorac Med. 2019;14(4):226\u201338.","journal-title":"Ann Thorac Med"},{"issue":"5","key":"2277_CR36","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/j.juro.2007.07.058","volume":"178","author":"M Castagnetti","year":"2007","unstructured":"Castagnetti M, Vezzu B, Laverda A, Zampieri S, Rigamonti W. Urological counseling and followup in pediatric tuberous sclerosis complex. J Urol. 2007;178(5):2155\u20139.","journal-title":"J Urol"},{"key":"2277_CR37","doi-asserted-by":"crossref","unstructured":"Siroky BJ, Towbin AJ, Trout AT, Schafer H, Thamann AR, Agricola KD, et al. Improvement in renal cystic disease of tuberous sclerosis complex after treatment with mammalian target of rapamycin inhibitor. J Pediatr. 2017;187:318-22 e2.","DOI":"10.1016\/j.jpeds.2017.05.015"},{"key":"2277_CR38","doi-asserted-by":"crossref","unstructured":"Kumar P, Zadjali F, Yao Y, Bissler JJ. Renal cystic disease in tuberous sclerosis complex. Exp Biol Med (Maywood). 2021:15353702211038378.","DOI":"10.1177\/15353702211038378"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02277-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02277-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02277-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T12:09:41Z","timestamp":1647346181000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02277-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2277"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02277-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"assertion":[{"value":"5 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients, or their legal guardian(s), consented for the Cincinnati Children\u2019s Hospital TSC Repository Database as approved by and study conducted according to the CCHMC Internal Review Board (IRB #2012-2317).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients, or their legal guardian(s), consented for publication as a part of the Cincinnati Children\u2019s Hospital TSC Repository Database as approved by the CCHMC Internal Review Board (IRB #2012-2317).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DMR, BKF, DEF, JW, DNF, ATT, and AJT declare that they have no competing interests related to this work. DAK recieves consulting and\/or speaker fees from Novartis Pharmaceuticals, Greenwich Bioscience, NobelPharma America, and REGENXBIO. Unrelated to this work: ATT receives consulting fees from Lantheus and AJT receives consulting fees from Applied Radiology.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}